preeclampsia. Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium, moderate pre-eclampsia, severe pre-eclampsia
Conditions
Interventions
Intervention 1: therapeutic intervention with drug( garlic capsule)
,with dose of 800mg, once a day, for 2 month (from the 28th up to 36th week of pregnancy period). Intervention 2: therapeutic int
Treatment - Drugs
therapeutic intervention with drug( garlic capsule)
,with dose of 800mg, once a day, for 2 month (from the 28th up to 36th week of pregnancy period)
therapeutic intervention with placebo, pharmaceutical starch with dose of 800mg, once a day, for 2 month(from the 28th up to 36th week of pregnancy period)
Sponsors
Vice Chancellor for Research of Islamic Azad University, Pharmaceutical Sciences Branch
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: first pregnancy, Turkmen ethnicity, being those with self or family history of preeclampsia, presence of chronic hypertension, and signing the informed consent form exclusion criteria: hypersensitivity to garlic, Lack of consent to participate in the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: at 28 week, at 32 week, at 36 week. Method of measurement: The use of mercury blood pressure device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShohreh Vosoogh
Golestan University of Medical Sciences
Outcome results
None listed